PRL-8-53; was: PRL 8-147: The Most Powerful Memory Enhancer?
#1171
Posted 17 August 2013 - 12:08 AM
#1172
Posted 18 August 2013 - 04:47 PM
Thanks for understanding
#1173
Posted 19 August 2013 - 02:26 PM
Edited by mait, 19 August 2013 - 02:28 PM.
#1174
Posted 19 August 2013 - 02:33 PM
#1175
Posted 19 August 2013 - 07:15 PM
#1176
Posted 19 August 2013 - 09:04 PM
A serotonin inhibitor, and a dopamine potentiator, AND a cholinergic agonist or modulator.
Is there any possibility that we could do research into the exact subtypes?
#1177
Posted 19 August 2013 - 09:35 PM
I'm curious about this compounds pharmacology.
A serotonin inhibitor, and a dopamine potentiator, AND a cholinergic agonist or modulator.
Is there any possibility that we could do research into the exact subtypes?
I've already posted a bit on that, but got 0 feedback on it. Posts should be 1-3 pages back or so.
#1178
Posted 21 August 2013 - 04:03 AM
I think we should be able to do our own in vitro studies of receptor activation? Any where to buy them?
#1179
Posted 21 August 2013 - 12:18 PM
sorry I missed that! You ended up no where though M4 activation leads to less motor activity, but less memory. Do you think its any other M subtype? If it released NGF I think that would cause less movement.
I think we should be able to do our own in vitro studies of receptor activation? Any where to buy them?
Remember that I'm a layman and really don't have much of an education (except wiki and reading studies). If we take a look at the muscarinic receptors (their functions) we see this:
Nicotinic receptors on the postganglionic neuron are responsible for the initial fast depolarization (Fast EPSP) of that neuron. As a consequence of this, nicotinic receptors are often cited as the receptor on the postganglionic neurons at the ganglion. However, the subsequent hyperpolarization (IPSP) and slow depolarization (Slow EPSP) that represent the recovery of the postganglionic neuron from stimulation are actually mediated by muscarinic receptors, types M2 and M1 respectively (discussed below).
Thus (if PRL-8-53 works the M1 subtype) it would probably be synergystic with a nicotinic agnoist.
But to add more relevant stuffs: I just added the "possible M4 receptor because of the placement" due to it being in the CNS (and because of this: "Muscarinic acetylcholine receptors possess a regulatory effect on dopaminergic neurotransmission."), I do however believe it's more likely M1-receptor.
Bit more for M1:
http://www.ncbi.nlm.nih.gov/pubmed/18454168Furthermore, 77-LH-28-1, but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations
I'm guessing an M1 receptor agonist (maybe not selective) and some non-selective dopamine/serotonin agonist/antagonist.
PRL-8-53 will most likely be ready in a few weeks from what my source tells me, but no idea how we're suppose to do an in-vitro study.
#1180
Posted 21 August 2013 - 01:56 PM
sorry I missed that! You ended up no where though M4 activation leads to less motor activity, but less memory. Do you think its any other M subtype? If it released NGF I think that would cause less movement.
I think we should be able to do our own in vitro studies of receptor activation? Any where to buy them?
Remember that I'm a layman and really don't have much of an education (except wiki and reading studies). If we take a look at the muscarinic receptors (their functions) we see this:Nicotinic receptors on the postganglionic neuron are responsible for the initial fast depolarization (Fast EPSP) of that neuron. As a consequence of this, nicotinic receptors are often cited as the receptor on the postganglionic neurons at the ganglion. However, the subsequent hyperpolarization (IPSP) and slow depolarization (Slow EPSP) that represent the recovery of the postganglionic neuron from stimulation are actually mediated by muscarinic receptors, types M2 and M1 respectively (discussed below).
Thus (if PRL-8-53 works the M1 subtype) it would probably be synergystic with a nicotinic agnoist.
But to add more relevant stuffs: I just added the "possible M4 receptor because of the placement" due to it being in the CNS (and because of this: "Muscarinic acetylcholine receptors possess a regulatory effect on dopaminergic neurotransmission."), I do however believe it's more likely M1-receptor.
Bit more for M1:http://www.ncbi.nlm....pubmed/18454168Furthermore, 77-LH-28-1, but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations
I'm guessing an M1 receptor agonist (maybe not selective) and some non-selective dopamine/serotonin agonist/antagonist.
PRL-8-53 will most likely be ready in a few weeks from what my source tells me, but no idea how we're suppose to do an in-vitro study.
PRL-8-53 might be a bit trickier to figure out because the effects of this compound might be related to bio active metabolite(s) of this compound. So simple in-vitro study wont be an all conclusive answer here. Although the creator of this compound itself attributed the effects of it mainly to acetylcholinergic function and secondarily to the modifying effects of monoaminergic neurotransmission, thus it would be really interesting to know the exact target of PRL-8-53 in Ach system (which may also help explain the monoaminergic modifying effects).
#1181
Posted 21 August 2013 - 10:55 PM
#1182
Posted 22 August 2013 - 05:45 PM
Just wondering if there were any spots left in the group buy?
Finally decided to see for myself.
#1183
Posted 22 August 2013 - 09:16 PM
#1184
Posted 23 August 2013 - 04:58 AM
Too late to get in on this?
bump I want to know too
#1185
Posted 23 August 2013 - 04:26 PM
I'm eager to hear everyones results though.
#1186
Posted 24 August 2013 - 07:16 PM
I'm curious about this compounds pharmacology.
A serotonin inhibitor, and a dopamine potentiator, AND a cholinergic agonist or modulator.
Is there any possibility that we could do research into the exact subtypes?
I've already posted a bit on that, but got 0 feedback on it. Posts should be 1-3 pages back or so.
thanks ill check it out
#1187
Posted 25 August 2013 - 04:10 AM
We still have a few spots available for those of you still interested in getting in on this group buy.
#1188
Posted 25 August 2013 - 08:34 AM
#1189
Posted 25 August 2013 - 09:59 AM
#1190
Posted 25 August 2013 - 01:43 PM
#1191
Posted 25 August 2013 - 02:18 PM
I'm eager to hear everyones results though.
Or any results at all.
#1192
Posted 26 August 2013 - 07:52 PM
Has this compounds excretion been mapped out in any studies?
#1193
Posted 27 August 2013 - 12:12 AM
#1194
Posted 30 August 2013 - 12:01 AM
#1195
Posted 30 August 2013 - 03:30 AM
#1196
Posted 30 August 2013 - 10:25 PM
Hi all,
An member on the forum has offered to test some for me, I am currently chatting to see what the 'thoroughness' of the testing is and will likely send a sample soon. While I want to identify the PLR, I also want to test and ensure there are no more nasty chemicals left behind.
rnapolymerase: If you'd be willing to conduct some testing to identify the compound and scan for any 'nasty' chemicals I'd glady send you some of my batch in exchange for the report.
I will keep everyone updated as news comes to hand, but sit tight as I'll likely have to send the stuff overseas so shipping alone will be a ~10 day turnaround time. If anyone has any advice on how to legally ship it as far as documentation etc goes, please shoot me a msg. I'd like to ship it legitemately to avoid any issues.
Oh, and if anyone has any colouracetam I'd gladly do a swap
Hey, any updates on what is going on?
#1197
Posted 31 August 2013 - 06:40 PM
#1198
Posted 02 September 2013 - 03:09 PM
#1199
Posted 02 September 2013 - 10:47 PM
#1200
Posted 02 September 2013 - 10:55 PM
36 user(s) are reading this topic
0 members, 36 guests, 0 anonymous users